Bank of America’s Tenax Therapeutics TENX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.99M | Buy |
136,428
+117,859
| +635% | +$1.51M | ﹤0.01% | 4216 |
|
|
2026
Q1 | $297K | Buy |
18,569
+14,789
| +391% | +$200K | ﹤0.01% | 5160 |
|
|
2025
Q4 | $46.1K | Buy |
3,780
+3,526
| +1,388% | +$30.7K | ﹤0.01% | 5868 |
|
|
2025
Q3 | $1.93K | Buy |
254
+5
| +2% | +$31 | ﹤0.01% | 7404 |
|
|
2025
Q2 | $1.43K | Buy |
249
+20
| +9% | +$116 | ﹤0.01% | 7471 |
|
|
2025
Q1 | $1.5K | Buy |
229
+201
| +718% | +$1.29K | ﹤0.01% | 7373 |
|
|
2024
Q4 | $173 | Hold |
28
| – | – | ﹤0.01% | 7623 |
|
|
2024
Q3 | $97 | Buy |
28
+12
| +75% | +$43 | ﹤0.01% | 7729 |
|
|
2024
Q2 | $48 | Buy |
+16
| New | +$57 | ﹤0.01% | 7848 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 8753 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 8630 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 8389 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 8081 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 7767 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 7362 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 7168 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 7121 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 7236 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 7389 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 7498 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 7375 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 7462 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 7321 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 7342 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 7250 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 7268 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 7167 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 7222 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 7302 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 6968 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 7371 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 7299 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 7463 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 7396 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 7406 |
|
|
2015
Q1 | – | Hold |
0
| – | – | – | 7550 |
|
|
2014
Q4 | – | Sell |
-13
| Closed | -$1.57M | – | 7951 |
|
|
2014
Q3 | $1.58M | Sell |
13
-10
| -43% | -$1.28M | ﹤0.01% | 3596 |
|
|
2014
Q2 | $2.94M | Buy |
+23
| New | +$3.55M | ﹤0.01% | 3029 |
|
|
2014
Q1 | – | Hold |
0
| – | – | – | 8068 |
|
|
2013
Q4 | – | Hold |
0
| – | – | – | 8135 |
|
|
2013
Q3 | – | Hold |
0
| – | – | – | 8037 |
|
|
2013
Q2 | – | Hold |
0
| – | – | – | 7406 |
|
Other funds holding TENX
VC
PA
IC
CS
RI
Bank of America's TENX Position: Q2 2026 in Review
Bank of America increased its Tenax Therapeutics (TENX) stake by 635% in Q2 2026, buying an estimated $1.51M and bringing the position to 136,428 shares worth $1.99M. The position accounts for ﹤0.01% of the portfolio, ranked #4216.
Bank of America first reported a position in TENX in Q2 2014 and has held it in 11 quarters since. The position peaked at $2.94M in Q2 2014. 111 funds tracked by Wall St. Rank hold TENX as of Q2 2026.
- Bank of America held 136,428 shares of Tenax Therapeutics worth $1.99M as of Q2 2026.
- Bank of America bought 117,859 Tenax Therapeutics shares in Q2 2026, an estimated $1.51M.
- Tenax Therapeutics made up ﹤0.01% of Bank of America's portfolio in Q2 2026, its #4216 holding.
- Bank of America first reported a position in Tenax Therapeutics in Q2 2014 and has held it in 11 quarters since.
- Bank of America's Tenax Therapeutics position peaked at $2.94M in Q2 2014.
- 111 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q2 2026.
Based on Bank of America's 13F filing for Q2 2026, filed 14 Aug 2026.